• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肥胖症的时间疗法。II. 氟苯丙胺治疗后肥胖者饮食行为随给药时间的变化]

[Chronotherapy of obesity. II. Variations in eating behavior in the obese after fenfluramine treatment in relation to time of administration].

作者信息

Di Vincenzo M, Guagnano M T, Della Loggia F, Sensi S

出版信息

Boll Soc Ital Biol Sper. 1982 Jun 30;58(12):740-4.

PMID:7104097
Abstract

The administration of Fenfluramine (F.) in a single dose in the morning provokes a different effect on eating behavior (E.B.) in comparison with the administration of the same dose three times/day. It is observed a shorter duration of eating (p less than 001); a decrease of total kcalories ingested during the day, and hunger feeling. These results are reviewed on the basis of present knowledge on drug-kinetic and on previous work in our laboratory which documented higher decrease of body weight and adipose mass when the F. was administered in a single dose in the morning than in the afternoon or three times a day.

摘要

与每日三次服用相同剂量的芬氟拉明相比,早上单次服用芬氟拉明(F.)对进食行为(E.B.)产生不同的影响。观察到进食持续时间更短(p小于0.001);白天摄入的总卡路里减少,饥饿感降低。根据目前关于药物动力学的知识以及我们实验室之前的工作对这些结果进行了综述,之前的工作记录了早上单次服用芬氟拉明比下午或一天三次服用时体重和脂肪量的降低幅度更大。

相似文献

1
[Chronotherapy of obesity. II. Variations in eating behavior in the obese after fenfluramine treatment in relation to time of administration].[肥胖症的时间疗法。II. 氟苯丙胺治疗后肥胖者饮食行为随给药时间的变化]
Boll Soc Ital Biol Sper. 1982 Jun 30;58(12):740-4.
2
[Chronotherapy of obesity. I. Effect of fenfluramine on the decrease of adipose mass in the obese, in relation to the time of administration].[肥胖症的时间治疗法。I. 氟苯丙胺对肥胖者脂肪量减少的影响与给药时间的关系]
Boll Soc Ital Biol Sper. 1982 Jun 30;58(12):736-9.
3
Long-term treatment with fenfluramine in obese subjects.芬氟拉明对肥胖受试者的长期治疗。
Int J Clin Pharmacol Res. 1985;5(4):247-53.
4
[Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].右芬氟拉明对肥胖患者饮食行为和体重的影响:奥地利全科医疗中异芬氟拉明的一项现场研究结果
Acta Med Austriaca. 1995;22(5):95-101; 104-9.
5
[Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].[芬氟拉明在肥胖受试者中的活性。药物剂量、血浆浓度与其对体重减轻的影响之间的关系]
Minerva Med. 1982 Jun 8;73(24):1703-10.
6
Dexfenfluramine influences dietary compliance and eating behaviors of obese subjects.
Nutr Rev. 1994 Feb;52(2 Pt 1):65-8.
7
Vitamin C and the anti-obesity effect of fenfluramine.
Int J Vitam Nutr Res. 1979;49(3):251-63.
8
Effects of fenfluramine on the metabolism of calcium and phosphorus in the rat: fenfluramine effects on Ca and P metabolism.芬氟拉明对大鼠钙和磷代谢的影响:芬氟拉明对钙和磷代谢的作用。
Cent Afr J Med. 1992 Mar;38(3):100-8.
9
Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.使用西布曲明和奥利司他治疗谁会减重?治疗成功的心理关联因素。
Diabetes Obes Metab. 2008 Jun;10(6):498-505. doi: 10.1111/j.1463-1326.2007.00740.x. Epub 2007 Jun 26.
10
Brain and nutrition. Dexfenfluramine weight control and regulation of eating patterns. Satellite symposium to the Collegium Internationale Neuro-Psychopharmacologicum, 15th C.I.N.P. congress. Puerto Rico, U.S.A., December 14-17, 1987. Proceedings.大脑与营养。右旋芬氟拉明与体重控制及饮食模式调节。国际神经精神药理学会卫星研讨会,第15届国际神经精神药理学会大会。美国波多黎各,1987年12月14日至17日。会议论文集。
Clin Neuropharmacol. 1988;11 Suppl 1:S1-223.

引用本文的文献

1
Circadian Dysfunction in Adipose Tissue: Chronotherapy in Metabolic Diseases.脂肪组织中的昼夜节律功能障碍:代谢性疾病的时间疗法
Biology (Basel). 2023 Aug 2;12(8):1077. doi: 10.3390/biology12081077.
2
Google trend analysis of climatic zone based Indian severe seasonal sensitive population.基于气候带的印度严重季节性敏感人群的谷歌趋势分析
BMC Public Health. 2020 Mar 12;20(1):306. doi: 10.1186/s12889-020-8399-0.